Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.

Abstract

As the COVID-19 pandemic shut down businesses and schools in 2020, global health authorities and governments kick-started the quest for a vaccine for the novel coronavirus. This case study details Operation Warp Speed, the $18 billion public-private partnership initiated by the US government to accelerate the research, development, manufacture and distribution of COVID-19 vaccine therapies. The case explores the history of public-private partnerships in the United States, and the ambitious US government effort to deliver 300 million doses of a COVID-19 vaccine by January 2021.

Time period

The events covered by this case took place in 2021.

Geographical setting

Region:
Americas

About

Abstract

As the COVID-19 pandemic shut down businesses and schools in 2020, global health authorities and governments kick-started the quest for a vaccine for the novel coronavirus. This case study details Operation Warp Speed, the $18 billion public-private partnership initiated by the US government to accelerate the research, development, manufacture and distribution of COVID-19 vaccine therapies. The case explores the history of public-private partnerships in the United States, and the ambitious US government effort to deliver 300 million doses of a COVID-19 vaccine by January 2021.

Settings

Time period

The events covered by this case took place in 2021.

Geographical setting

Region:
Americas

Related